Answers are grounded in this paper and cite their sources.
Here, we report the synthesis of a designed multi-pharmacophore ligand derived from the linkage of a delta selective peptide antagonist (Dmt-Tic) and a mu/kappa morphinan agonist butorphan (MCL 101) through a two methylene spacer. The new compound MCL 450 maintains the same characteristics as those the two reference compounds. MCL 450 represents a useful starting point for the synthesis of other multiple opioid ligands endowed with analgesic properties with low tolerance and dependence.
No takes yet. Share an insight, caveat, or question.
Neumeyer et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: